Exponent, Inc. Profile Avatar - Palmy Investing

Exponent, Inc.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment …
Consulting Services
US, Menlo Park [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
28.79 30.96 32.97 91.08 94.56 94.91 94.53 94.96 94.79 93.44 93.81 24.04 93.01 93.17 25.29
Profit Margin
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Margin
14.60 17.38 19.62 19.69 18.89 20.86 22.04 19.65 20.72 24.10 20.40 20.82 23.36 27.44 20.74
EPS Growth
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Return on Assets (ROA)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Return on Equity (ROE)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Return on Invested Capital (ROIC)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Equity
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/EBITDA
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Capitalization
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Interest Debt per Share USD
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt Growth
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Liquidity
Current Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Quick Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cash Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Receivables Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Payables Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Asset Turnover
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Coverage
Interest Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Asset Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cash Flow Coverage (CFGR)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Coverage
-800 -1,100 5,233,700 -1,300 -600 -1,400 -3,100 -800 -600 -4,900 - - - - - - 6,700 - -
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
- - 200 200 100 100 100 100 100 100 100 100 - - 100 100 500
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Price/Earnings (P/E)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Price/Book (P/B)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Price/Sales (P/S)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Price/Cash Flow (P/CF)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
End of EXPO's Analysis
CIK: 851520 CUSIP: 30214U102 ISIN: US30214U1025 LEI: - UEI: -
Secondary Listings
EXPO has no secondary listings inside our databases.